EUVIMEDEUVIMED entdecken
Crossref

The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway

Yan Gao, Sixiang Wang, Yuehong Gao, Li Yang iD

Basic & Clinical Pharmacology & Toxicology · 2024

DOI: 10.1111/bcpt.14096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2024. Verfasst von Yan Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Innovation and Attracting Talents "111" base, Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bio…. Hauptthemen laut MEDLINE: NF-kappa B, Chondrocytes, Osteoarthritis, Knee, Macrophages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation and Attracting Talents Program for College and University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation significantly contributes to the progression of osteoarthritis (OA), and an anti‐inflammatory small molecule derived from medicinal herbs could be a potential drug candidate for OA. Herein, we investigated the function and mechanism of Evodiamine (EAE), the active ingredient from Evodia rutaecarpa , in chondrocytes and macrophages in vitro and in vivo. The cytotoxicity of EAE was determined using an MTT assay. And the anti‐inflammatory and anti‐extracellular matrix (ECM) degradation effects of EAE were investigated using qRT‐PCR, western blot (WB), immunofluorescence (IF). Inductively Coupled Plasma Atomic Emission Spectrometry (ICP‐AES), Fluo‐4 AM, IF and AutoDock were used to elucidate the molecular mechanisms and signalling pathways of the reducing‐inflammatory properties of EAE on chondrocytes in vitro. Moreover, the effect of EAE on macrophage polarization was detected by IF and flow cytometry (FC). Ultimately, we explored the in vivo therapeutic efficacy of EAE in an anterior cruciate ligament transection (ACLT)‐induced OA model. The finding demonstrated that EAE blocked the phosphorylation of IKBα and Ca 2+ influx, thereby curbing inflammation and ECM degradation. Additionally, EAE can prevent the polarization towards the M1 phenotype. Thus, our findings suggest that EAE has great potential as a therapeutic drug for the treatment of OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BChondrocytesOsteoarthritis, KneeMacrophagesRats, Sprague-DawleyAnti-Inflammatory AgentsEvodiaQuinazolinesCalciumAnimalsRatsMaleSignal TransductionDisease Models, AnimalInflammationPlant ExtractsNF-KappaB Inhibitor alphaPhosphorylation

Stichwörter der Autor:innen

EvodiamineNF‐κB/calcium influxanti‐inflammatoryosteoarthritispolarization

Substanzen

NF-kappa BAnti-Inflammatory AgentsQuinazolinesCalciumevodiaminePlant ExtractsNF-KappaB Inhibitor alphaNfkbia protein, rat

Autor:innen und Institutionen

  • National Innovation and Attracting Talents "111" base, Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, China.
  • College of Biology and Environmental Sciences, Jishou University, Jishou, China.

ORCID-Profile: Li Yang

Förderung

  • National Natural Science Foundation of China
  • Innovation and Attracting Talents Program for College and University

Zitieren

APA

Gao, Y., Wang, S., Gao, Y., & Yang, L. (2024). The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.14096

Vancouver

Gao Y, Wang S, Gao Y, Yang L. The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway. Basic & Clinical Pharmacology & Toxicology. 2024. doi:10.1111/bcpt.14096

BibTeX
@article{Gao2024,
  author = {Gao, Yan and Wang, Sixiang and Gao, Yuehong and Yang, Li},
  title = {The active ingredient of Evodia rutaecarpa reduces inflammation in knee osteoarthritis rats through blocking calcium influx and NF‐κB pathway},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2024},
  doi = {10.1111/bcpt.14096}
}
Kostenlos starten →